Trial Profile
Entorhinal, Parahippocampal, and Inferior Temporal F18-T807 Suvr Correlates with CSF Total Tau and Tau T181P in Cognitively Normal Elderly
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Oct 2015
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- 20 Oct 2015 New trial record